The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 9, 2012, Pages 2211-2218

  Yu, M ^a   Ji, Y ^a   Jiang, H ^a   Wu, K ^a   Ju, L ^a   Tang, X ^a   Wu, M ^a   Jiang, Q ^b  

^a Nanjing Second Hospital   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATION PERIOD; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOPROPHYLAXIS; MAJOR CLINICAL STUDY; PATIENT SELECTION; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHEMOPREVENTION; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HUMANS; IMMUNOTHERAPY; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 84866362553     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1557-2     Document Type: Article

References (38)

1. Zeng Z, Guan L, An P, Sun S, O'Brien SJ, Winkler CA (2008) A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis 8:1
2. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS (2007) Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 166:813-818
3. Lu J, Zhou Y, Lin X, Jiang Y, Tian R, Zhang Y, Wu J, Zhang F, Wang Y, Bi S (2009) General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007. PLoS One 4:e8467
4. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ (2004) Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 10:3215-3217
5. Xia GL, Gong J, Wang JJ, Meng ZD, Jia ZY, Cao HL, Liu CB (2003) Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection. Zhonghua Liu Xing Bing Xue Za Zhi 24:362-365
6. Ranger-Rogez S, Alain S, Denis F (2002) Hepatitis viruses: mother to child transmission. Pathol Biol (Paris) 50:568-575
7. Zou HB, Chen Y, Zhang H, Duan ZP, Li J, Zhuang H, Liang XF, Pan CQ (2010) Prevention of hepatitis B virus vertical transmission: current situation and challenges. Zhonghua Gan Zang Bing Za Zhi 18:556-558
8. Li YX, Gao QW, Zhang YH, Guo Y, Li BW, Wang HX, Wang YL, Wang YM (2004) An investigation on the transmission routes and early diagnosis of intrauterine infection induced by hepatitis B virus. Zhonghua Gan Zang Bing Za Zhi 12:18-20
9. Yue YF, Jiang H, Shi L, Li LF, Xi BS, Yu YL, Chen GF (2004) Study on the mechanism of intrauterine infection of hepatitis B virus. Zhonghua Fu Chan Ke Za Zhi 39:224-226
10. Arfaoui D, Fkih M, Hafsa AE, Kaabia N, Azzouz M (2010) Hepatitis B and pregnancy. Tunis Med 88:383-389
11. Yang Y, Deng L, Li X, Shi Z, Jiang P, Chen D, Yu Y,Wang Z, Tang X, Zhao S, Feng L, Tan H, Ma L (2011) Analysis of prognosisassociated factors in fulminant viral hepatitis during pregnancy in China. Int J Gynaecol Obstet: Official Organ Int FederationGynaecol Obstet 114:242-245
12. Yu M, Ji Y, Jiang H, Ju L, Wu K, Kan N (2011) Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus. Int J Gynaecol Obstet: Official Organ Int Federation Gynaecol Obstet 114:33-36
13. Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW (1989) Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1:406-410
14. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL (2003) Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 10:294-297
15. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA (2010) Liver disease in pregnancy. Lancet 375:594-605
16. Poblano A, Figueroa L, Figueroa-Damian R, Schnaas L (2004) Effects of prenatal exposure to zidovudine and lamivudine on brainstem auditory evoked potentials in infants from HIV-infected women. Proc West Pharmacol Soc 47:46-49
17. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y (2004) Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 10:910-912
18. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M (2009) Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 16:94-103
19. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS (2007) Management of hepatitis B: summary of a clinical research workshop. Hepatology 45:1056-1075
20. Dieu E, Bocket L, Coursier J, Canva V, Gonzalez F, Boulanger L, Mathurin P, Dharancy S (2009) Hepatitis B viral infection treated with lamivudine during pregnancy. Gastroenterol Clin Biol 33:391-393
21. Huang K, Lin S (2000) Nationwide vaccination: a success story in Taiwan. Vaccine 18(Suppl 1):S35-38
22. Ilboudo D, Sawadogo A, Simpore J (2002) Mother-to-child transmission of hepatitis B virus, in Ouagadougou, Burkina Faso. Med Trop (Mars) 62:99-101
23. Koedijk FD, op de Coul EL, Boot HJ, van de Laar MJ (2007) Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions. Ned Tijdschr Geneeskd 151:2389-2394
24. Ilboudo D, Simpore J, Ouermi D, Bisseye C, Sagna T, Odolini S, Buelli F, Pietra V, Pignatelli S, Gnoula C, Nikiema JB, Musumeci S (2010) Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. Braz J Infect Dis 14:219-224
25. Lin J, Liao S, Guo GZ, Huang WY, Wang CP, Zhou M, Wu CL, Kang CY (2002) Significance of hepatitis B virus DNA quantity in transmission between mothers and infants. Zhonghua Erke Zazhi 40:84-87
26. Boland GJ, Veldhuijzen IK, Janssen HL, van der Eijk AA, Wouters MG, Boot HJ (2009) Management and treatment of pregnant women with hepatitis B. Ned Tijdschr Geneeskd 153:A905
27. Zhu YY, Mao YZ, Wu WL, Cai QX, Lin XH (2010) Does hepatitis B virus prenatal transmission result in postnatal immunoprophylaxis failure? Clin Vaccine Immunol 17:1836-1841
28. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L (2003) Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 9:1501-1503
29. El Beitune P, Duarte G, Foss MC, Montenegro RM Jr, Quintana SM, Figueiro-Filho EA, Nogueira AA (2005) Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant. Diabetes Care 28:856-859
30. Watts DH, Covington DL, Beckerman K, Garcia P, Scheuerle A, Dominguez K, Ross B, Sacks S, Chavers S, Tilson H (2004) Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy. Am J Obstet Gynecol 191:985-992
31. Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis: IJID: Official Publication Int Society Infect Dis 14:e622-634
32. Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116:147-159
33. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK (2002) Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 359:1488-1489
34. Zoulim F (2002) A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection. Drug Saf 25:497-510
35. Potthoff A, Rifai K, Wedemeyer H, Deterding K, Manns M, Strassburg C (2009) Successful treatment of fulminant hepatitis B during pregnancy. Z Gastroenterol 47:667-670
36. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ (2000) Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15:1356-1361
37. Gish RG (2009) Hepatitis B treatment: current best practices, avoiding resistance. Cleve Clin J Med 76(Suppl 3):S14-19
38. Vcev A (2009) Management of side effects during antiviral therapy. Acta Med Croatica 63:463-467